Well, I am not discounting the concept. I just don't think that is where the thought process is in the year 2013 in medicine as it relates to this drug. I am looking for $70- $80 million in revenue this year. I believe Leerink's model shows cash use of $226 million which wouldn't leave a lot left..balance woudl be gone in Q1 2014 absent a partnership or sale
Market Data 
Markets 
AI
